Your participation in the study will last about 8 months. You will have a screening visit to see if you qualify, 16 study sessions, and 8 behavioral smoking cessation counseling sessions. You will be completing questionnaires at visits and over the phone. If you agree to join the study, you will be asked to self-inject the medication liraglutide, or a placebo, daily for the duration of the study.